News

Commonwealth Fund: Low-income families have advantages in top performing states

Expect a few missteps as provisions phase in over time

AMA says obesity is a disease but the decision is up for debate

New members likely to have more chronic conditions

More complex reimbursement contracts make it tougher on providers

Shared Savings model will have to mature and refine to adapt to industry changes

Anticipate larger ACOs eventually opting for formularies

Physician-led models seem to have an advantage

New cost control ideas will be needed in the future

One of many things that will cause rates to increase between 2013 and 2014.

CDC is concerned because young adults and children are beginning to use e-cigarettes, and the products’ safety is uncertain.

Managed care appears to fare well under PPACA

Convenient sound bites do not take the place of true intelligence.

Will the 34 federally-facilitated and state-partnership exchange programs be sufficient?

Managed care organizations will be remiss if they don’t seriously consider the evolving competitive landscape.

New network designs drive quality through data sharing

Consumers need in-person assistance to understand the health law and what it means to them

While HHS touts big savings for consumers, insurers feel the pinch on prices

Employers are threatening to cut hours and workers to avoid PPACA requirements

Pharmacy leaders say benchmark plans too limited and PPACA too prescriptive

A global Accenture study shows patients want access to EMRs so they can get more involved in their care

Stakeholders weigh the pros and cons of convenient care clinics found in drug stores and grocery outlets

Young invincibles who are used to their parents' plans will no doubt want to continue coverage

The significance and impact of the primary care physician shortage is evaluated by industry experts.

A key initiative for Seaside Health Plan is California Children’s Services demo

Families USA drills down to estimate the number of subsidized enrollees

Digoxin, commonly used to treat heart conditions, was associated with a 72% higher rate of death among adults with newly diagnosed heart failure, according to a Kaiser Permanente study in the September issue of Circulation: Cardiovascular Quality and Outcomes.

In adult patients with type 2 diabetes mellitus (T2DM) who are uncontrolled on metformin and sulfonylurea, dapagliflozin can be added to help improve HbA1c and reduce fasting plasma glucose, body weight, and seated systolic blood pressure, according to results from a study presented at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain, in September.

A new study may set a new standard for the treatment of venous thromboembolism (VTE) with a single oral anticoagulant.